Check-Cap (CHEK) Competitors $1.84 -0.21 (-10.24%) Closing price 04:00 PM EasternExtended Trading$1.88 +0.03 (+1.90%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CHEK vs. DRCT, SLGL, TMDIF, SRTS, APT, NEPH, NMTC, ZYXI, CLGN, and MODDShould you be buying Check-Cap stock or one of its competitors? The main competitors of Check-Cap include Direct Digital (DRCT), Sol-Gel Technologies (SLGL), Titan Medical (TMDIF), Sensus Healthcare (SRTS), Alpha Pro Tech (APT), Nephros (NEPH), NeuroOne Medical Technologies (NMTC), Zynex (ZYXI), CollPlant Biotechnologies (CLGN), and Modular Medical (MODD). Check-Cap vs. Its Competitors Direct Digital Sol-Gel Technologies Titan Medical Sensus Healthcare Alpha Pro Tech Nephros NeuroOne Medical Technologies Zynex CollPlant Biotechnologies Modular Medical Check-Cap (NASDAQ:CHEK) and Direct Digital (NASDAQ:DRCT) are related small-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk. Is CHEK or DRCT more profitable? Check-Cap has a net margin of 0.00% compared to Direct Digital's net margin of -25.99%. Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A Direct Digital -25.99%N/A -36.29% Which has more risk & volatility, CHEK or DRCT? Check-Cap has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Direct Digital has a beta of 5.88, suggesting that its share price is 488% more volatile than the S&P 500. Do analysts prefer CHEK or DRCT? Direct Digital has a consensus target price of $6.00, suggesting a potential upside of 1,702.88%. Given Direct Digital's stronger consensus rating and higher probable upside, analysts plainly believe Direct Digital is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Direct Digital 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better earnings & valuation, CHEK or DRCT? Direct Digital has higher revenue and earnings than Check-Cap. Check-Cap is trading at a lower price-to-earnings ratio than Direct Digital, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$25.15M-$3.00-0.61Direct Digital$62.29M0.12-$6.24M-$1.83-0.18 Does the media refer more to CHEK or DRCT? In the previous week, Direct Digital had 1 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Direct Digital and 2 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.95 beat Direct Digital's score of 0.75 indicating that Check-Cap is being referred to more favorably in the media. Company Overall Sentiment Check-Cap Positive Direct Digital Positive Do institutionals and insiders have more ownership in CHEK or DRCT? 1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 4.0% of Direct Digital shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 46.9% of Direct Digital shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryDirect Digital beats Check-Cap on 11 of the 14 factors compared between the two stocks. Get Check-Cap News Delivered to You Automatically Sign up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHEK vs. The Competition Export to ExcelMetricCheck-CapMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.76M$6.85B$6.01B$10.23BDividend YieldN/A1.16%5.66%4.69%P/E Ratio-0.6126.2985.3526.57Price / SalesN/A189.69582.95179.01Price / CashN/A22.0838.3262.20Price / Book-7.365.1112.726.53Net Income-$25.15M$178.04M$3.30B$275.87M7 Day Performance-18.94%-2.07%1.07%-1.40%1 Month Performance155.56%8.24%7.61%5.16%1 Year Performance24.32%27.37%79.71%31.51% Check-Cap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHEKCheck-Cap0.2096 of 5 stars$1.84-10.2%N/A+43.1%$10.76MN/A-0.6180Analyst ForecastGap DownDRCTDirect Digital3.3178 of 5 stars$0.31-5.7%$6.00+1,805.4%-84.3%$7.52M$36.46M-0.1760News CoveragePositive NewsAnalyst ForecastGap UpHigh Trading VolumeSLGLSol-Gel Technologies0.6296 of 5 stars$28.74-0.9%N/A+510.0%$80.76M$11.54M-23.3750News CoverageAnalyst ForecastTMDIFTitan MedicalN/A$0.45+6.0%N/A+1,349.2%$51.32M$17.63M-0.3650Gap UpSRTSSensus Healthcare2.787 of 5 stars$3.17+2.3%$8.00+152.4%-46.2%$50.96M$41.81M-52.8340Analyst ForecastAPTAlpha Pro Tech2.8695 of 5 stars$4.81-1.2%N/A-16.6%$50.38M$58.56M13.00120NEPHNephros1.4014 of 5 stars$4.57+2.7%$5.50+20.4%+262.4%$47.17M$14.16M38.0830News CoverageAnalyst ForecastNMTCNeuroOne Medical Technologies2.7143 of 5 stars$0.90-2.1%$2.23+147.2%+9.6%$45.95M$3.45M-6.0020News CoverageAnalyst ForecastZYXIZynex2.5661 of 5 stars$1.47+1.4%$4.90+233.3%-81.3%$43.93M$192.35M-1.56770Analyst ForecastCLGNCollPlant Biotechnologies2.8089 of 5 stars$2.90-7.6%$11.50+296.6%-48.2%$39.93M$510K-2.5770Positive NewsAnalyst ForecastMODDModular Medical0.5287 of 5 stars$0.70-0.6%N/A-67.1%$38.92MN/A-1.3720 Related Companies and Tools Related Companies DRCT Alternatives SLGL Alternatives TMDIF Alternatives SRTS Alternatives APT Alternatives NEPH Alternatives NMTC Alternatives ZYXI Alternatives CLGN Alternatives MODD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHEK) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Check-Cap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
